Physician profile

Mark Alan Mccurdy

Urology · Arlington, TX

NPI 1255327383

$7,229.32

in general payments reported to CMS, 2019-2025

48 companies · $1,616 in 2025

The $1,616 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,285.83
Travel and Lodging$1,141.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Procept Biorobotics Corporation $1,203.46 2024-2025 Aquabeam System
Teleflex LLC $879.19 2021-2025 Barrigel
Axonics, INC. $725.90 2020-2024 Axonics, Bulkamid
Astellas Pharma US INC $510.38 2019-2025 Xtandi
Janssen Biotech, INC. $279.80 2019-2025 Erleada, Akeega
Urogen Pharma, INC. $273.35 2021-2025
Abbvie INC. $267.85 2019-2025
Sumitomo Pharma America, INC. $251.76 2024-2025 Orgovyx, Gemtesa
Boston Scientific Corporation $241.57 2019-2025 Spaceoar Vue System - 10ml
Olympus America INC. $228.11 2020-2025 Itind System
Endo USA, INC. $205.16 2024-2025 Xiaflex, Aveed
Valencia Technologies Corporation $185.76 2025 Ecoin Device Kit
180 Medical, INC. $182.32 2022-2024 Gentlecath
Tolmar, INC. $144.44 2024-2025 Eligard, Jatenzo
Agiliti Surgical, INC. $140.81 2024-2025 Koelis Trinity Mri/US Fusion, Koelis Trinity Fusion Biopsy System
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Immunitybio, INC. $112.32 2025
Antares Pharma, INC. $96.76 2019-2024 Xyosted
Dendreon Pharmaceuticals LLC $95.98 2019
Endo Pharmaceuticals INC. $88.30 2019-2020
Coloplast Corp $82.94 2022-2024
Zyla Life Sciences, INC. $80.56 2019-2020
Convatec INC. $75.90 2024-2025
Accord Healthcare, INC. $71.37 2022-2024
Medtronic, INC. $68.95 2021-2023 Interstim
Eisai INC. $59.72 2024
Bluewind Medical $58.89 2024-2025
Allergan, INC. $53.17 2019-2020
Ferring Pharmaceuticals INC. $52.88 2024-2025 Adstiladrin
Bayer Healthcare Pharmaceuticals INC. $51.88 2024
Medtronic USA, INC. $42.86 2019
Urovant Sciences INC $37.39 2022
Ambu INC. $37.20 2022-2025
Civco Medical Instruments $37.17 2024-2025
Verity Pharmaceuticals INC. $36.62 2025 Trelstar
Calyxo, INC. $28.15 2025 Cvac Aspiration System
Blue Earth Diagnostics $25.38 2024
Innovation Technologies INC $24.19 2025 Irrisept
Travere Therapeutics, INC. $23.18 2019
Cook Medical LLC $21.20 2024 Resonance
Genzyme Corporation $20.88 2019
Biocomposites INC $20.55 2023 Stimulan
Progenics Pharmaceuticals, INC. $19.74 2024
Shire North American Group INC $19.70 2019
Azurity Pharmaceuticals, INC. $18.13 2025 Azmiro
Pfizer INC. $15.88 2022
Therapeuticsmd, INC. $13.02 2019
Mallinckrodt Enterprises LLC $11.82 2019
Mission Pharmacal Company $6.78 2024 Uribel Tabs

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark Alan Mccurdy

$7,229.32

in general payments reported 2019-2025

Years
2019-2025
Top company
Procept Biorobotics Corporation
Context
The $1,616 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/238583/mark-alan-mccurdy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.